Tradename: ProQuad

Proper Name: Measles, Mumps, Rubella and Varicella Virus Vaccine Live

Indication: To include safety and immunogenicity data that supports the intramuscular route as an additional route of administration for ProQuad, and associated product labeling changes. 

ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.

Approval Date: 02/27/2023

Manufacturer: Merck Sharp & Dohme Corp.